Physician profile
Andres Mesa
NPI 1891721338
$102,503.46
in general payments reported to CMS, 2019-2025
50 companies · $2,750 in 2025
The $2,750 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $14K · 2021: $2,354 · 2022: $7,915 · 2023: $5,039 · 2024: $3,975 · 2025: $2,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,187 · Travel and Lodging: $2,559 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,186.73 |
| Travel and Lodging | $2,558.68 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $73,827.81 | 2019-2023 | |
| Bard Peripheral Vascular, INC. | $6,140.07 | 2021-2024 | Venclose Maven Catheter |
| Boston Scientific Corporation | $5,901.16 | 2019-2025 | Emblem Mri S-Icd, General - Therapies, Resonate El Icd Vr |
| Medtronic, INC. | $4,987.52 | 2021-2025 | Corevalve Evolut R, Venaseal, Micra |
| Abbott Laboratories | $1,924.98 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint, Dragonfly Opstar |
| Novartis Pharmaceuticals Corporation | $1,087.47 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $948.40 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $945.89 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $913.32 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $910.31 | 2020-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $646.96 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $641.22 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $375.16 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $337.95 | 2022-2025 | Wegovy, Ozempic |
| Venclose INC. | $304.74 | 2020 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $254.37 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $205.52 | 2019-2025 | Lifevest |
| Preventice Services, LLC | $205.05 | 2019-2021 | |
| Tactile Systems Technology INC | $191.28 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $181.22 | 2019-2024 | |
| Pfizer INC. | $154.57 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $144.96 | 2021 | |
| Cardiovascular Systems INC. | $141.69 | 2023 | Diamondback Peripheral |
| Chiesi USA, INC. | $103.50 | 2020-2022 | |
| Asahi Intecc USA, INC. | $90.58 | 2024 | Peripheral Vascular |
| Bayer Healthcare Pharmaceuticals INC. | $85.77 | 2022-2025 | |
| Baxter Healthcare | $78.59 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $77.73 | 2023-2024 | Inpefa |
| Angiodynamics, INC. | $65.69 | 2019-2022 | |
| Heartflow, INC. | $63.52 | 2024 | |
| Irhythm Technologies, INC. | $62.38 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Scpharmaceuticals INC. | $43.07 | 2025 | |
| Cashflow Solutions, LLC | $41.25 | 2022-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Kiniksa Pharmaceuticals, Ltd. | $40.13 | 2023 | Arcalyst |
| Cleerly, INC. | $37.16 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Agepha Pharma Fz LLC | $37.12 | 2024-2025 | Lodoco |
| Rigel Pharmaceuticals, INC. | $34.70 | 2025 | Gavreto, Rezlidhia, Tavalisse |
| Saranas, INC. | $31.34 | 2021 | |
| Surmodics, INC. | $26.61 | 2022 | |
| Janssen Biotech, INC. | $26.04 | 2024 | Erleada |
| Lilly USA, LLC | $23.63 | 2021 | |
| Eisai INC. | $22.54 | 2022 | |
| Ge Healthcare | $21.31 | 2020 | |
| Cvrx, INC. | $20.34 | 2021 | |
| Endologix LLC | $18.57 | 2020 | |
| Daiichi Sankyo INC. | $18.34 | 2023 | Injectafer |
| Exelixis INC. | $17.70 | 2025 | Cabometyx |
| Avinger INC. | $15.24 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $15.21 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $13.78 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andres Mesa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.